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Prevotella intermedia has long been known to be as the principal etiologic agent of periodontal
diseases and associated with various systemic diseases. Previous studies showed that the
intra-species difference exists in capacity of bioﬁlm formation, antibiotic resistance, and
serological reaction among P. intermedia strains. Here we report the genome sequence of P.
intermedia SUNY aB G8-9K-3 (designated ATCC49046) that displays a relatively high antimi-
crobial resistant and bioﬁlm-forming capacity. Genome sequencing information provides
important clues in understanding the genetic bases of phenotypic differences among P.
intermedia strains.revotella intermedia
ntimicrobial resistant
ioﬁlm-forming capacity
© 2016 Sociedade Brasileira de Microbiologia. Published by Elsevier Editora Ltda. This is
an  open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).
deﬁne its genetic makeup by sequencing its genome.revotella intermedia is an obligate anaerobic gram-negative
od-shape bacterium that has long been known to be associ-
ted with periodontal diseases as well as systemic diseases
uch as cystic ﬁbrosis and chronic bronchitis.1 There have
een evidences to show that the intra-species difference
xists: Takahashi et al.2 reported that P. intermedia SUNY aB G8-
K-3 (designated ATCC 49046) produces 2-fold-larger amount
f monospecies bioﬁlm than other strains, including ATCC
T5611 (type strain), and ATCC49046 bioﬁlm exhibited high-
evel resistance to antibiotics. Furthermore, the bioactivity
f ATCC49046 bioﬁlm was even signiﬁcantly increased after
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that serogroup A, represented by ATCC 25611T, accounted for
only 5% of the 79 isolates and 6% of the 66 patient plaque sam-
ples, while most of the P. intermedia isolates (55%) and subjects
(52%) were classiﬁed as being in the serogroup C, represented
by ATCC 49046. The wealth of information on genomic char-
acteristics and virulence traits of ATCC49046 compelled us tol Sciences, Department of Maxillofacial Biomedical Engineering,
emun-gu, Seoul 02447, Republic of Korea.
The bacterial genomic DNA was extracted and sequenc-
ing library was constructed following paired-end sequencing
on the Illumina Hi-Seq 2500 platform. In total, 14,668,776
lsevier Editora Ltda. This is an open access article under the CC
.
m i c r
r6  b r a z i l i a n j o u r n a l o f 
paired-end read pairs (2 × 100 bp) were obtained. After ﬁltering
out low quality of the raw reads, A5 assembler (version A5-
miseq 20140604)4 with default parameters was used for the
construction of the genome. The genome assembly resulted
in 46 scaffolds (>500-bp length). The draft genome size
is 2,673,338 bp and G + C content is 43.47%. Gene annota-
tion of the draft genome has been performed using Prokka
1.105 and total 2248 protein coding sequences (CDSs), 44
tRNA, 1 tmRNA and 3 repeat regions were annotated. In
the annotated genome, Cas1, 2 and 9 genes are located
in the same scaffold and 5 clustered regularly interspaced
short palindromic repeats (CRISPRs) arrays were identiﬁed
by PILER-CR.6 P. intermedia ATCC49046 is predicted to encode
various resistance determinants toward cobalt, zinc and cad-
mium,  and genes involved in drug resistance: different copies
of beta-lactamases, virulence factor BrkB, virulence asso-
ciated protein E, and multidrug resistance proteins such
as MdtN and NorM. Multidrug/efﬂux transporters, such
as ABC-type multidrug transport system, multidrug trans-
porter AcrB, and MATE  efﬂux family proteins were also
found.
Global pairwise comparison of the genome sequences
between ATCC25611T and ATCC49046 strains showed that 94%
of genome regions were similar with each other. Meanwhile
single nucleotide polymorphism (SNP) analysis performed by
MUMmer  package7 identiﬁed 1643 orthologous genes having
at least one SNP, of which 51 genes, including chemotaxis
protein CheY, membrane proteins, TonB-dependent receptor,
polysaccharide biosynthesis protein, collagen-binding pro-
tein, secretion protein and capsid assembly protein, are
statistically signiﬁcantly highly variable. These results provide
important clues in understanding the genetic bases of pheno-
typic differences among P. intermedia strains.
This Whole Genome Shotgun project has been deposited at
DDBJ/ENA/GenBank under the accession LBGT00000000. The o b i o l o g y 4 8 (2 0 1 7) 5–6
version described in this paper is version LBGT00000000.1. The
BioProject ID in GenBank is PRJNA281562.
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